CRP and cancer: In further research on the CRP/Alb ratio for predicting the overall survival of patients with cancer, available research indicated that the CRP/Alb ratio was an efficacious prognostic factor in hepatocellular carcinoma, esophageal squamous cell carcinoma and NPC [14,38,39].